Page 423 - ANUAL REPORT MOH 2017

317 websites and 440 social media accounts were found to be selling Pharmaceutical products that
violate the provisions of the law enforced have been monitored and investigated. During this operation
period, 32,226 parcels, luggage and cargo were inspected. Of these, 458 postal and courier parcels,
luggage and cargo worth RM1,921,731.50 were also seized. Raids were also conducted on 49
unlicensed premises which mostly sell online pharmaceutical products nationwide. During the raids,
129,022 pharmaceutical products that violated the law were seized for further action. The seizure value
was estimated at RM1,693,116.00. 22 digital devices such as computers, tablets and mobile phones
used as a medium to market the product were also confiscated.

Image 3
Pangea X Operations

Source: Pharmacy Enforcement Division, MoH

NATIONAL SITUATIONAL MAPPING OF ANTIMICROBIAL CONSUMPTION IN MALAYSIA STUDY
Malaysia had been selected by WHO Western Pacific Region to conduct the National Situational
Mapping of Antimicrobial Consumption. Objectives of the study include to identify the existing
antimicrobial consumption monitoring systems in the country, as well as the gaps and challenges in
antimicrobial consumption data collection, to assess the current procurement system and to study the
feasibility of introducing WHO methodology on antimicrobial consumption monitoring. The study was
conducted in February 2017 by appointed investigators from the School of Pharmaceutical Sciences,
Universiti Sains Malaysia, while the Pharmaceutical Care Section acted as study coordinator. Data were
collected from Kuala Lumpur Hospital, Tengku Ampuan Rahimah Hospital, Sultanah Aminah Hospital
dan Penang Hospital. The study findings were presented by the Deputy Director of Pharmaceutical
Care Section in the Workshop on Monitoring Antimicrobial Consumption in Select Western Pacific
Countries, which was held on 30 to 31 March 2017 in Manila, The Philippines.

NATIONAL PHARMACEUTICAL REGULATORY AGENCY (NPRA) AS A WHO COLLABORATING
CENTRE FOR REGULATORY CONTROL OF PHARMACEUTICALS

The National Pharmaceutical Regulatory Agency (NPRA) has been given international recognition as a
“WHO Collaborating Centre for Regulatory Control of Pharmaceuticals” in the year 1996. This recognition
is an acknowledgement from World Health Organization (WHO) for NPRA’s contribution in the field
of regulatory affairs. This recognition has attracted foreign regulatory agencies to undergo training in
NPRA. Throughout 2017, NPRA received six (6) visitors from Brunei Darussalam, Nepal and Sri Lanka.

422 ANNUAL REPORT 2017 MINISTRY OF HEALTH MALAYSIA